Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis

K N Sorensen1, R A Sobel, K V Clemons

  • 1Department of Medicine, Division of Infectious Diseases, Santa Clara Valley Medical Center, San Jose, California 95128-2699, USA.

Insights

This study compared fluconazole (FCZ) and itraconazole (ITZ) for treating coccidioidal meningitis in rabbits. Both antifungals effectively reduced fungal load and disease severity, though neither achieved a cure.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Coccidioidal meningitis is a severe fungal infection requiring prolonged treatment with limited curative options.
  • The rabbit model is crucial for evaluating therapeutic strategies against Coccidioides immitis infections in the central nervous system.

Purpose of the Study:

  • To compare the therapeutic efficacy of fluconazole (FCZ) and itraconazole (ITZ) in a rabbit model of coccidioidal meningitis.
  • To assess the impact of FCZ and ITZ on fungal burden, histopathology, cerebrospinal fluid parameters, and survival.

Main Methods:

  • New Zealand white rabbits with hydrocortisone treatment were intracisternally infected with Coccidioides immitis.
  • Animals received oral treatment with polyethylene glycol 200 (PEG), FCZ, or ITZ daily for 28 days.
  • Fungal load (CFU), histopathologic severity, CSF analysis, and survival rates were evaluated.

Main Results:

  • Both FCZ and ITZ significantly reduced C. immitis in the brain and spinal cord compared to PEG controls.
  • Histopathologic severity, CSF protein, and leukocyte counts were equally reduced by FCZ and ITZ.
  • Both drugs extended survival and reduced neurological signs, with FCZ showing better control of certain symptoms and ITZ of fever.

Conclusions:

  • Fluconazole and itraconazole demonstrate comparable efficacy in treating experimental coccidioidal meningitis in rabbits.
  • While effective in reducing disease burden and improving outcomes, neither FCZ nor ITZ provided a complete cure.
  • Azole treatment modulated the immune response, reducing antibody development in the cerebrospinal fluid.